Combination Immunotherapy (Relatlimab/Nivolumab)–Associated Capillary Leak Syndrome: A Case Report
Immune checkpoint inhibitors (ICIs) are the preferred first-line treatment of metastatic melanoma. While dual immunotherapy improves efficacy, it also increases the risk for immune-related adverse events (irAEs). Capillary leak syndrome (CLS) is a rare and potentially serious irAE that can be challe...
Kaydedildi:
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American College of Physicians
2025-10-01
|
| Seri Bilgileri: | Annals of Internal Medicine: Clinical Cases |
| Online Erişim: | https://www.acpjournals.org/doi/10.7326/aimcc.2025.0753 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|